Global Prader-Willi Syndrome Therapeutics Market Research Report 2023

Report ID: 1978032 | Published Date: Jan 2025 | No. of Page: 86 | Base Year: 2024 | Rating: 5 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Prader-Willi Syndrome Therapeutics Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
        1.2.2 Beloranib
        1.2.3 Betahistine Hydrochloride
        1.2.4 Diazoxide Choline CR
        1.2.5 FE-992097
        1.2.6 NOX-B11
        1.2.7 Others
    1.3 Market by Application
        1.3.1 Global Prader-Willi Syndrome Therapeutics Market Share by Application: 2017 VS 2021 VS 2028
        1.3.2 Clinic
        1.3.3 Hospital
        1.3.4 Others
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global Prader-Willi Syndrome Therapeutics Market Perspective (2017-2028)
    2.2 Prader-Willi Syndrome Therapeutics Growth Trends by Region
        2.2.1 Prader-Willi Syndrome Therapeutics Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 Prader-Willi Syndrome Therapeutics Historic Market Size by Region (2017-2022)
        2.2.3 Prader-Willi Syndrome Therapeutics Forecasted Market Size by Region (2023-2028)
    2.3 Prader-Willi Syndrome Therapeutics Market Dynamics
        2.3.1 Prader-Willi Syndrome Therapeutics Industry Trends
        2.3.2 Prader-Willi Syndrome Therapeutics Market Drivers
        2.3.3 Prader-Willi Syndrome Therapeutics Market Challenges
        2.3.4 Prader-Willi Syndrome Therapeutics Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Prader-Willi Syndrome Therapeutics Players by Revenue
        3.1.1 Global Top Prader-Willi Syndrome Therapeutics Players by Revenue (2017-2022)
        3.1.2 Global Prader-Willi Syndrome Therapeutics Revenue Market Share by Players (2017-2022)
    3.2 Global Prader-Willi Syndrome Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Prader-Willi Syndrome Therapeutics Revenue
    3.4 Global Prader-Willi Syndrome Therapeutics Market Concentration Ratio
        3.4.1 Global Prader-Willi Syndrome Therapeutics Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Prader-Willi Syndrome Therapeutics Revenue in 2021
    3.5 Prader-Willi Syndrome Therapeutics Key Players Head office and Area Served
    3.6 Key Players Prader-Willi Syndrome Therapeutics Product Solution and Service
    3.7 Date of Enter into Prader-Willi Syndrome Therapeutics Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Prader-Willi Syndrome Therapeutics Breakdown Data by Type
    4.1 Global Prader-Willi Syndrome Therapeutics Historic Market Size by Type (2017-2022)
    4.2 Global Prader-Willi Syndrome Therapeutics Forecasted Market Size by Type (2023-2028)
5 Prader-Willi Syndrome Therapeutics Breakdown Data by Application
    5.1 Global Prader-Willi Syndrome Therapeutics Historic Market Size by Application (2017-2022)
    5.2 Global Prader-Willi Syndrome Therapeutics Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America Prader-Willi Syndrome Therapeutics Market Size (2017-2028)
    6.2 North America Prader-Willi Syndrome Therapeutics Market Size by Country (2017-2022)
    6.3 North America Prader-Willi Syndrome Therapeutics Market Size by Country (2023-2028)
    6.4 United States
    6.5 Canada
7 Europe
    7.1 Europe Prader-Willi Syndrome Therapeutics Market Size (2017-2028)
    7.2 Europe Prader-Willi Syndrome Therapeutics Market Size by Country (2017-2022)
    7.3 Europe Prader-Willi Syndrome Therapeutics Market Size by Country (2023-2028)
    7.4 Germany
    7.5 France
    7.6 U.K.
    7.7 Italy
    7.8 Russia
    7.9 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Prader-Willi Syndrome Therapeutics Market Size (2017-2028)
    8.2 Asia-Pacific Prader-Willi Syndrome Therapeutics Market Size by Country (2017-2022)
    8.3 Asia-Pacific Prader-Willi Syndrome Therapeutics Market Size by Country (2023-2028)
    8.4 China
    8.5 Japan
    8.6 South Korea
    8.7 Southeast Asia
    8.8 India
    8.9 Australia
9 Latin America
    9.1 Latin America Prader-Willi Syndrome Therapeutics Market Size (2017-2028)
    9.2 Latin America Prader-Willi Syndrome Therapeutics Market Size by Country (2017-2022)
    9.3 Latin America Prader-Willi Syndrome Therapeutics Market Size by Country (2023-2028)
    9.4 Mexico
    9.5 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Prader-Willi Syndrome Therapeutics Market Size (2017-2028)
    10.2 Middle East & Africa Prader-Willi Syndrome Therapeutics Market Size by Country (2017-2022)
    10.3 Middle East & Africa Prader-Willi Syndrome Therapeutics Market Size by Country (2023-2028)
    10.4 Turkey
    10.5 Saudi Arabia
    10.6 UAE
11 Key Players Profiles
    11.1 Chong Kun Dang Pharmaceutical Corp.
        11.1.1 Chong Kun Dang Pharmaceutical Corp. Company Detail
        11.1.2 Chong Kun Dang Pharmaceutical Corp. Business Overview
        11.1.3 Chong Kun Dang Pharmaceutical Corp. Prader-Willi Syndrome Therapeutics Introduction
        11.1.4 Chong Kun Dang Pharmaceutical Corp. Revenue in Prader-Willi Syndrome Therapeutics Business (2017-2022)
        11.1.5 Chong Kun Dang Pharmaceutical Corp. Recent Development
    11.2 Essentialis, Inc.
        11.2.1 Essentialis, Inc. Company Detail
        11.2.2 Essentialis, Inc. Business Overview
        11.2.3 Essentialis, Inc. Prader-Willi Syndrome Therapeutics Introduction
        11.2.4 Essentialis, Inc. Revenue in Prader-Willi Syndrome Therapeutics Business (2017-2022)
        11.2.5 Essentialis, Inc. Recent Development
    11.3 Ferring International Center S.A.
        11.3.1 Ferring International Center S.A. Company Detail
        11.3.2 Ferring International Center S.A. Business Overview
        11.3.3 Ferring International Center S.A. Prader-Willi Syndrome Therapeutics Introduction
        11.3.4 Ferring International Center S.A. Revenue in Prader-Willi Syndrome Therapeutics Business (2017-2022)
        11.3.5 Ferring International Center S.A. Recent Development
    11.4 LG Life Sciences, Ltd.
        11.4.1 LG Life Sciences, Ltd. Company Detail
        11.4.2 LG Life Sciences, Ltd. Business Overview
        11.4.3 LG Life Sciences, Ltd. Prader-Willi Syndrome Therapeutics Introduction
        11.4.4 LG Life Sciences, Ltd. Revenue in Prader-Willi Syndrome Therapeutics Business (2017-2022)
        11.4.5 LG Life Sciences, Ltd. Recent Development
    11.5 P2D Bioscience
        11.5.1 P2D Bioscience Company Detail
        11.5.2 P2D Bioscience Business Overview
        11.5.3 P2D Bioscience Prader-Willi Syndrome Therapeutics Introduction
        11.5.4 P2D Bioscience Revenue in Prader-Willi Syndrome Therapeutics Business (2017-2022)
        11.5.5 P2D Bioscience Recent Development
    11.6 Pfizer Inc.
        11.6.1 Pfizer Inc. Company Detail
        11.6.2 Pfizer Inc. Business Overview
        11.6.3 Pfizer Inc. Prader-Willi Syndrome Therapeutics Introduction
        11.6.4 Pfizer Inc. Revenue in Prader-Willi Syndrome Therapeutics Business (2017-2022)
        11.6.5 Pfizer Inc. Recent Development
    11.7 Rhythm Pharmaceuticals
        11.7.1 Rhythm Pharmaceuticals Company Detail
        11.7.2 Rhythm Pharmaceuticals Business Overview
        11.7.3 Rhythm Pharmaceuticals Prader-Willi Syndrome Therapeutics Introduction
        11.7.4 Rhythm Pharmaceuticals Revenue in Prader-Willi Syndrome Therapeutics Business (2017-2022)
        11.7.5 Rhythm Pharmaceuticals Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details

List of Tables
    Table 1. Global Prader-Willi Syndrome Therapeutics Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
    Table 2. Key Players of Beloranib
    Table 3. Key Players of Betahistine Hydrochloride
    Table 4. Key Players of Diazoxide Choline CR
    Table 5. Key Players of FE-992097
    Table 6. Key Players of NOX-B11
    Table 7. Key Players of Others
    Table 8. Global Prader-Willi Syndrome Therapeutics Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
    Table 9. Global Prader-Willi Syndrome Therapeutics Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 10. Global Prader-Willi Syndrome Therapeutics Market Size by Region (2017-2022) & (US$ Million)
    Table 11. Global Prader-Willi Syndrome Therapeutics Market Share by Region (2017-2022)
    Table 12. Global Prader-Willi Syndrome Therapeutics Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 13. Global Prader-Willi Syndrome Therapeutics Market Share by Region (2023-2028)
    Table 14. Prader-Willi Syndrome Therapeutics Market Trends
    Table 15. Prader-Willi Syndrome Therapeutics Market Drivers
    Table 16. Prader-Willi Syndrome Therapeutics Market Challenges
    Table 17. Prader-Willi Syndrome Therapeutics Market Restraints
    Table 18. Global Prader-Willi Syndrome Therapeutics Revenue by Players (2017-2022) & (US$ Million)
    Table 19. Global Prader-Willi Syndrome Therapeutics Market Share by Players (2017-2022)
    Table 20. Global Top Prader-Willi Syndrome Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Prader-Willi Syndrome Therapeutics as of 2021)
    Table 21. Ranking of Global Top Prader-Willi Syndrome Therapeutics Companies by Revenue (US$ Million) in 2021
    Table 22. Global 5 Largest Players Market Share by Prader-Willi Syndrome Therapeutics Revenue (CR5 and HHI) & (2017-2022)
    Table 23. Key Players Headquarters and Area Served
    Table 24. Key Players Prader-Willi Syndrome Therapeutics Product Solution and Service
    Table 25. Date of Enter into Prader-Willi Syndrome Therapeutics Market
    Table 26. Mergers & Acquisitions, Expansion Plans
    Table 27. Global Prader-Willi Syndrome Therapeutics Market Size by Type (2017-2022) & (US$ Million)
    Table 28. Global Prader-Willi Syndrome Therapeutics Revenue Market Share by Type (2017-2022)
    Table 29. Global Prader-Willi Syndrome Therapeutics Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 30. Global Prader-Willi Syndrome Therapeutics Revenue Market Share by Type (2023-2028)
    Table 31. Global Prader-Willi Syndrome Therapeutics Market Size by Application (2017-2022) & (US$ Million)
    Table 32. Global Prader-Willi Syndrome Therapeutics Revenue Market Share by Application (2017-2022)
    Table 33. Global Prader-Willi Syndrome Therapeutics Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 34. Global Prader-Willi Syndrome Therapeutics Revenue Market Share by Application (2023-2028)
    Table 35. North America Prader-Willi Syndrome Therapeutics Market Size by Country (2017-2022) & (US$ Million)
    Table 36. North America Prader-Willi Syndrome Therapeutics Market Size by Country (2023-2028) & (US$ Million)
    Table 37. Europe Prader-Willi Syndrome Therapeutics Market Size by Country (2017-2022) & (US$ Million)
    Table 38. Europe Prader-Willi Syndrome Therapeutics Market Size by Country (2023-2028) & (US$ Million)
    Table 39. Asia-Pacific Prader-Willi Syndrome Therapeutics Market Size by Region (2017-2022) & (US$ Million)
    Table 40. Asia-Pacific Prader-Willi Syndrome Therapeutics Market Size by Region (2023-2028) & (US$ Million)
    Table 41. Latin America Prader-Willi Syndrome Therapeutics Market Size by Country (2017-2022) & (US$ Million)
    Table 42. Latin America Prader-Willi Syndrome Therapeutics Market Size by Country (2023-2028) & (US$ Million)
    Table 43. Middle East & Africa Prader-Willi Syndrome Therapeutics Market Size by Country (2017-2022) & (US$ Million)
    Table 44. Middle East & Africa Prader-Willi Syndrome Therapeutics Market Size by Country (2023-2028) & (US$ Million)
    Table 45. Chong Kun Dang Pharmaceutical Corp. Company Detail
    Table 46. Chong Kun Dang Pharmaceutical Corp. Business Overview
    Table 47. Chong Kun Dang Pharmaceutical Corp. Prader-Willi Syndrome Therapeutics Product
    Table 48. Chong Kun Dang Pharmaceutical Corp. Revenue in Prader-Willi Syndrome Therapeutics Business (2017-2022) & (US$ Million)
    Table 49. Chong Kun Dang Pharmaceutical Corp. Recent Development
    Table 50. Essentialis, Inc. Company Detail
    Table 51. Essentialis, Inc. Business Overview
    Table 52. Essentialis, Inc. Prader-Willi Syndrome Therapeutics Product
    Table 53. Essentialis, Inc. Revenue in Prader-Willi Syndrome Therapeutics Business (2017-2022) & (US$ Million)
    Table 54. Essentialis, Inc. Recent Development
    Table 55. Ferring International Center S.A. Company Detail
    Table 56. Ferring International Center S.A. Business Overview
    Table 57. Ferring International Center S.A. Prader-Willi Syndrome Therapeutics Product
    Table 58. Ferring International Center S.A. Revenue in Prader-Willi Syndrome Therapeutics Business (2017-2022) & (US$ Million)
    Table 59. Ferring International Center S.A. Recent Development
    Table 60. LG Life Sciences, Ltd. Company Detail
    Table 61. LG Life Sciences, Ltd. Business Overview
    Table 62. LG Life Sciences, Ltd. Prader-Willi Syndrome Therapeutics Product
    Table 63. LG Life Sciences, Ltd. Revenue in Prader-Willi Syndrome Therapeutics Business (2017-2022) & (US$ Million)
    Table 64. LG Life Sciences, Ltd. Recent Development
    Table 65. P2D Bioscience Company Detail
    Table 66. P2D Bioscience Business Overview
    Table 67. P2D Bioscience Prader-Willi Syndrome Therapeutics Product
    Table 68. P2D Bioscience Revenue in Prader-Willi Syndrome Therapeutics Business (2017-2022) & (US$ Million)
    Table 69. P2D Bioscience Recent Development
    Table 70. Pfizer Inc. Company Detail
    Table 71. Pfizer Inc. Business Overview
    Table 72. Pfizer Inc. Prader-Willi Syndrome Therapeutics Product
    Table 73. Pfizer Inc. Revenue in Prader-Willi Syndrome Therapeutics Business (2017-2022) & (US$ Million)
    Table 74. Pfizer Inc. Recent Development
    Table 75. Rhythm Pharmaceuticals Company Detail
    Table 76. Rhythm Pharmaceuticals Business Overview
    Table 77. Rhythm Pharmaceuticals Prader-Willi Syndrome Therapeutics Product
    Table 78. Rhythm Pharmaceuticals Revenue in Prader-Willi Syndrome Therapeutics Business (2017-2022) & (US$ Million)
    Table 79. Rhythm Pharmaceuticals Recent Development
    Table 80. Research Programs/Design for This Report
    Table 81. Key Data Information from Secondary Sources
    Table 82. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Prader-Willi Syndrome Therapeutics Market Share by Type: 2021 VS 2028
    Figure 2. Beloranib Features
    Figure 3. Betahistine Hydrochloride Features
    Figure 4. Diazoxide Choline CR Features
    Figure 5. FE-992097 Features
    Figure 6. NOX-B11 Features
    Figure 7. Others Features
    Figure 8. Global Prader-Willi Syndrome Therapeutics Market Share by Application in 2021 & 2028
    Figure 9. Clinic Case Studies
    Figure 10. Hospital Case Studies
    Figure 11. Others Case Studies
    Figure 12. Prader-Willi Syndrome Therapeutics Report Years Considered
    Figure 13. Global Prader-Willi Syndrome Therapeutics Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 14. Global Prader-Willi Syndrome Therapeutics Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 15. Global Prader-Willi Syndrome Therapeutics Market Share by Region: 2021 VS 2028
    Figure 16. Global Prader-Willi Syndrome Therapeutics Market Share by Players in 2021
    Figure 17. Global Top Prader-Willi Syndrome Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Prader-Willi Syndrome Therapeutics as of 2021)
    Figure 18. The Top 10 and 5 Players Market Share by Prader-Willi Syndrome Therapeutics Revenue in 2021
    Figure 19. North America Prader-Willi Syndrome Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 20. North America Prader-Willi Syndrome Therapeutics Market Share by Country (2017-2028)
    Figure 21. United States Prader-Willi Syndrome Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 22. Canada Prader-Willi Syndrome Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 23. Europe Prader-Willi Syndrome Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 24. Europe Prader-Willi Syndrome Therapeutics Market Share by Country (2017-2028)
    Figure 25. Germany Prader-Willi Syndrome Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 26. France Prader-Willi Syndrome Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 27. U.K. Prader-Willi Syndrome Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 28. Italy Prader-Willi Syndrome Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 29. Russia Prader-Willi Syndrome Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 30. Nordic Countries Prader-Willi Syndrome Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 31. Asia-Pacific Prader-Willi Syndrome Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 32. Asia-Pacific Prader-Willi Syndrome Therapeutics Market Share by Region (2017-2028)
    Figure 33. China Prader-Willi Syndrome Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 34. Japan Prader-Willi Syndrome Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 35. South Korea Prader-Willi Syndrome Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 36. Southeast Asia Prader-Willi Syndrome Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 37. India Prader-Willi Syndrome Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 38. Australia Prader-Willi Syndrome Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 39. Latin America Prader-Willi Syndrome Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 40. Latin America Prader-Willi Syndrome Therapeutics Market Share by Country (2017-2028)
    Figure 41. Mexico Prader-Willi Syndrome Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 42. Brazil Prader-Willi Syndrome Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 43. Middle East & Africa Prader-Willi Syndrome Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 44. Middle East & Africa Prader-Willi Syndrome Therapeutics Market Share by Country (2017-2028)
    Figure 45. Turkey Prader-Willi Syndrome Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 46. Saudi Arabia Prader-Willi Syndrome Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 47. Chong Kun Dang Pharmaceutical Corp. Revenue Growth Rate in Prader-Willi Syndrome Therapeutics Business (2017-2022)
    Figure 48. Essentialis, Inc. Revenue Growth Rate in Prader-Willi Syndrome Therapeutics Business (2017-2022)
    Figure 49. Ferring International Center S.A. Revenue Growth Rate in Prader-Willi Syndrome Therapeutics Business (2017-2022)
    Figure 50. LG Life Sciences, Ltd. Revenue Growth Rate in Prader-Willi Syndrome Therapeutics Business (2017-2022)
    Figure 51. P2D Bioscience Revenue Growth Rate in Prader-Willi Syndrome Therapeutics Business (2017-2022)
    Figure 52. Pfizer Inc. Revenue Growth Rate in Prader-Willi Syndrome Therapeutics Business (2017-2022)
    Figure 53. Rhythm Pharmaceuticals Revenue Growth Rate in Prader-Willi Syndrome Therapeutics Business (2017-2022)
    Figure 54. Bottom-up and Top-down Approaches for This Report
    Figure 55. Data Triangulation
    Figure 56. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Chong Kun Dang Pharmaceutical Corp.
Essentialis, Inc.
Ferring International Center S.A.
LG Life Sciences, Ltd.
P2D Bioscience
Pfizer Inc.
Rhythm Pharmaceuticals
Frequently Asked Questions
Prader-Willi Syndrome Therapeutics report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Prader-Willi Syndrome Therapeutics report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Prader-Willi Syndrome Therapeutics report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Pulse Duplicator

The research report includes specific segments by region (country), by manufacturers, by Type and ... Read More

PVDC Film

The research report includes specific segments by region (country), by manufacturers, by Type and ... Read More

Refined Salt

The research report includes specific segments by region (country), by company, by Type and by Ap ... Read More